UK review finds statins are cost effective in secondary prevention.
Kmietowicz
Z
Z
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D000960:Hypolipidemic Agents / Q000191:economics / Q000627:therapeutic use*
D000960:Hypolipidemic Agents